Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

CSE:HUGE - Post Discussion

FSD Pharma Inc > FSD Pharma my thoughts for today
View:
Post by DavidRosenberg on Feb 04, 2022 11:04am

FSD Pharma my thoughts for today

https://www.fsdpharma.com

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)

I am a shareholder

FSD Pharma has 3 drug candidates check out the website to learn more.

What makes them unique? They have a new approach to combat Multiple Sclerosis by restoring the damage that was done to the myelin sheath.

Im sharing this info in hopes that someone important can read it a potential cure for MS, in preclinical mouse models with auto immune multiple sclerosis the mouse was cured using the drug that FSD Pharma has. Human trials are yet to be started.

Then they have a pyschoactive drug candidate awaiting patent that used #artificialintelliegence / AI to create a completely new molecule to combat major depressive disorder which is a neuropsychiatric disorder.

Lastly a new phase 2 indication is currently being analyzed for inflammatory conditions ?

FSD PEA short form for Palmitoylethanolamide , a potent anti inflammatory drug they have the ultramicronized form of this substance and the patent is good until 2034.

and most important of all they have a strong biotech team based out of Canada via University Health Network and University of Toronto led by Lakshmi Kotra.

I wish more #analyst 's were able to cover this story. #Lifesci #SternIR #CoreIR #Argotpartners #soleburytrout #BurnsMcClellan #kcsa #Pfizer #Moderna #Sanofi #Merck #JNJ #Jpmorgan #Goldmansachs #westwicke

$HUGE #Nasdaq #Biotech #Healthcare #Institutional #Lifescience #MultipleSclerosis #Remyelination #Neurodegenerative #Inflammatory #MajorDepression #Pharmaceuticals #MS #demyelinating #novartis #GlaxoSmithKline
#EliLilly #roche #abbvie #health
Comment by Mil_Man54 on Feb 04, 2022 11:15am
Look at that....this paid PR message was brought to you by David Rosenberg....and I'm pretty sure that analysts would not support your narrative for FSD....it would more than likely be a cautionary tale of how to tank a stock through poor decisions, mismanagement, infighting, hype with no susbstance, and above all greed....so you may not what to pull that thread pumper.
Comment by Walter333 on Feb 04, 2022 11:59am
Great, so the man who holds a track record of an over 93% failure rate in start-ups with his leadership along with the destruction of retail shareholder value has regained the reigns and is back for more. He's doing such a wonderful job with PUMP (World Class Extractions) and others, investors should have no worries with such leadership back in control. Bokhari had to go, but don't fool ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities